Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY
Chemomab Therapeutics Q4 EPS $(0.26) Up From $(0.72) YoY
Chemomab Therapeutics第四季度每股收益美元(0.26美元)高於同比增長0.72美元
Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.26) per share. This is a 63.89 percent increase over losses of $(0.72) per share from the same period last year.
Chemomab Therapeutics(納斯達克股票代碼:CMMB)報告稱,季度每股虧損爲0.26美元。這比去年同期每股虧損0.72美元(0.72美元)增長了63.89%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。